Log in

Relevant bibliographies by topics / HIV treatment adherence / Journal articles

To see the other types of publications on this topic, follow the link: HIV treatment adherence.

Journal articles on the topic 'HIV treatment adherence'

Author: Grafiati

Published: 4 June 2021

Last updated: 4 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'HIV treatment adherence.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Cooper, Curtis L., and Ed Mills. "Comparison of first antiretroviral treatment duration and outcome in HIV, HIV–HBV and HIV–HCV infection." International Journal of STD & AIDS 18, no. 8 (2007): 546–50. http://dx.doi.org/10.1258/095646207781439838.

Full text

Abstract:

Hepatitis C virus (HCV) and hepatitis B virus (HBV) co-infection may differentially influence HIV treatment duration and outcome. This was assessed at The Ottawa Hospital Immunodeficiency Clinic in first-time highly active antiretroviral therapy (HAART) recipients visited between January 2000 and December 2004. Of 968 patients, 526/700 (75%) HIV, 173/230 (75%) HIV–HCV and 30/38 (79%) HIV–HBV-infected patients initiated HAART. Co-infected patients stopped treatment sooner (HBV – 10 months, HCV – 9 months) than HIV mono-infected (17 months) ( P<0.001). Injection drug history predicted shorter

APA, Harvard, Vancouver, ISO, and other styles

2

Wagner, Glenn, Karen Chan Osilla, Jeffrey Garnett, et al. "Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients." AIDS Research and Treatment 2011 (2011): 1–7. http://dx.doi.org/10.1155/2011/903480.

Full text

Abstract:

Background. Hepatitis C (HCV) treatment efficacy among HIV patients is limited by poor treatment adherence and tolerance, but few studies have examined the psychosocial determinants of treatment adherence and outcomes.Methods. Chart abstracted and survey data were collected on 72 HIV patients who had received pegylated interferon and ribavirin to assess correlates of treatment adherence, completion, and sustained virologic response (SVR).Results. Nearly half (46%) the sample had active psychiatric problems and 13% had illicit drug use at treatment onset; 28% reported <100% treatment adheren

APA, Harvard, Vancouver, ISO, and other styles

3

Sharma, B., and K. Joshi. "Treatment adherence of antiretroviral therapy among people living with HIV/AIDS." Journal of Chitwan Medical College 6, no. 3 (2017): 56–61. http://dx.doi.org/10.3126/jcmc.v6i3.16701.

Full text

Abstract:

Adherence to Antiretroviral therapy (ART)is a principle predictor for the success of Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome treatment. Highly Active Antiretroviral Therapy (HAART) has led to the reduction of mortality and the improvement of the quality of people living with HIV/AIDS. It has been estimated that at least 95% adherence with therapy is required to reduce HIV viral load. Non-adherence to treatment can lead to inadequate suppression of viral replication, continued destruction of CD4 cells, progressive decline in immune function and disease progression.

APA, Harvard, Vancouver, ISO, and other styles

4

Stirratt, Michael J., and Christopher M. Gordon. "HIV Treatment Adherence Research and Intervention." Journal of HIV/AIDS & Social Services 6, no. 1-2 (2007): 9–22. http://dx.doi.org/10.1300/j187v06n01_02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Miguez-Burbano, Maria Jose, Luis Espinoza, and John E. Lewis. "HIV Treatment Adherence and Sexual Functioning." AIDS and Behavior 12, no. 1 (2007): 78–85. http://dx.doi.org/10.1007/s10461-006-9197-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Hornschuh, Stefanie, Janan Janine Dietrich, Celokuhle Tshabalala, and Fatima Laher. "Antiretroviral Treatment Adherence: Knowledge and Experiences among Adolescents and Young Adults in Soweto, South Africa." AIDS Research and Treatment 2017 (2017): 1–8. http://dx.doi.org/10.1155/2017/5192516.

Full text

Abstract:

Human immunodeficiency virus (HIV) management of adolescents and young adults (AYAs) is particularly pertinent to sub-Saharan Africa, where the pediatric HIV burden is marked. Antiretroviral treatment (ART) adherence is a major challenge for AYAs. This qualitative study explored knowledge and experiences of adherence amongst AYAs attending treatment at the Perinatal HIV Research Unit (PHRU), Soweto, South Africa. Four focus group discussions (FGDs) and eight in-depth interviews (IDIs) were conducted with HIV-infected 15–25-year-old ART recipients. Transcripts were coded thematically. Participa

APA, Harvard, Vancouver, ISO, and other styles

7

Sánchez Peña, Sara, María del Mar Pastor Bravo, Miguel Ángel Cánovas Tomás, Pilar Almansa-Martínez, Caridad Peñalver Guillen, and Ismael Jiménez-Ruiz. "Factores relacionados con la adherencia al tratamiento antirretroviral en mujeres con VIH: Un estudio mixto con diseño secuencial." Enfermería Global 20, no. 2 (2021): 1–34. http://dx.doi.org/10.6018/eglobal.437711.

Full text

Abstract:

Introducción: El VIH/Sida afecta cada vez a más mujeres. La adherencia al tratamiento antirretroviral es decisiva en la calidad de vida de las personas infectadas. Objetivos: El objetivo del estudio es determinar el grado de adherencia manifestada en un grupo de mujeres con VIH/Sida, con TAR e identificar los factores y circunstancias que influyen en su adherencia.Metodología: Se ha realizado un estudio con diseño mixto secuencial explicativo. Los sujetos de estudio son 86 mujeres diagnosticadas con VIH/Sida en tratamiento con TARGA. Resultados: Se recogieron datos cualitativos de 18 de ellas.

APA, Harvard, Vancouver, ISO, and other styles

8

Stirratt, Michael J., and Christopher M. Gordon. "Adherence to biomedical HIV prevention methods: Considerations drawn from HIV treatment adherence research." Current HIV/AIDS Reports 5, no. 4 (2008): 186–92. http://dx.doi.org/10.1007/s11904-008-0027-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Wagner, Glenn J., Mary Slaughter, and Bonnie Ghosh-Dastidar. "Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda." Journal of the International Association of Providers of AIDS Care (JIAPAC) 16, no. 1 (2016): 91–97. http://dx.doi.org/10.1177/2325957416677121.

Full text

Abstract:

We examined the relationship between depression (symptom type, diagnostic severity, and change over time) and adherence to HIV antiretroviral therapy (ART) with data from 3 longitudinal studies (N = 1021) of patients starting ART in Uganda. The Patient Health Questionnaire was used to assess depressive symptoms (total score; somatic and cognitive subscales) and categorize severity level. At baseline, 9% had major depression and 30% had minor depression; 82% were adherent (reported no missed ART doses in the past 7 days) at month 6 and 85% at month 12. Controlling for demographic and medical co

APA, Harvard, Vancouver, ISO, and other styles

10

Johnson, Mallory O., Torsten B. Neilands, Samantha E. Dilworth, Stephen F. Morin, Robert H. Remien, and Margaret A. Chesney. "The Role of Self-Efficacy in HIV Treatment Adherence: Validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES)." Journal of Behavioral Medicine 30, no. 5 (2007): 359–70. http://dx.doi.org/10.1007/s10865-007-9118-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Meena, Sunil Kumar, Rudresh Negi, Shailendra Singh Chaudhary, and Sunil Kumar Misra. "Adherence to anti-retroviral therapy and factors influencing it among HIV/AIDS adult patients in Agra: a cross-sectional study." International Journal Of Community Medicine And Public Health 6, no. 8 (2019): 3373. http://dx.doi.org/10.18203/2394-6040.ijcmph20193458.

Full text

Abstract:

Background: HIV/AIDS remains a significant global public health problem. With approximately 56% HIV patients in India receiving treatment, adherence to drugs is a crucial element for successful management. Sustainable development goals, National Strategic plan for HIV/AIDS and STI (2017-24) and 90-90-90 target pushing towards ending of AIDS epidemic require adequate adherence and this research estimates the adherence, associated factors and reasons for non-compliance.Methods: This analytical cross sectional study was undertaken on 160 HIV patients from an ART Centre. A pre-structured, pilot te

APA, Harvard, Vancouver, ISO, and other styles

12

Belayihun, Bekele, and Rahma Negus. "Antiretroviral Treatment Adherence Rate and Associated Factors among People Living with HIV in Dubti Hospital, Afar Regional State, East Ethiopia." International Scholarly Research Notices 2015 (April 9, 2015): 1–5. http://dx.doi.org/10.1155/2015/187360.

Full text

Abstract:

Introduction. Antiretroviral Therapy has transformed HIV infection into a chronic manageable disease; it requires near perfect adherence rates (as high as 95%). In this study, we assessed antiretroviral treatment adherence rate and associated factors among people living with HIV in Dubti Hospital. Methods. A retrospective cross-sectional study design was conducted within February 1–30, 2014. All HIV-infected patients above the age of 18 years who took first line Antiretroviral Therapy were eligible for inclusion of the study. Adherence Scale was used for labeling patients as adherent or nonadh

APA, Harvard, Vancouver, ISO, and other styles

13

Rintamaki, Lance, Kami Kosenko, Timothy Hogan, et al. "The Role of Stigma Management in HIV Treatment Adherence." International Journal of Environmental Research and Public Health 16, no. 24 (2019): 5003. http://dx.doi.org/10.3390/ijerph16245003.

Full text

Abstract:

Social stigma is linked to improper HIV treatment adherence, but how stigma impairs adherence outcomes is poorly understood. This study included 93 people living with HIV in the United States who participated in focus groups or one-on-one interviews regarding how stigma might affect medication management. Latent content analysis and constant comparative techniques of participant responses that were produced three thematic groupings that described how participants (a) orient to HIV stigma, (b) manage HIV stigma in ways that directly impair treatment adherence, and (c) manage HIV stigma in ways

APA, Harvard, Vancouver, ISO, and other styles

14

Villacorta, R., X. Han, B. Clark, J. G. Hou, P. A. Miner, and J. McCombs. "Factors Affecting Adherence With Hiv Treatment Guidelines." Value in Health 17, no. 3 (2014): A278. http://dx.doi.org/10.1016/j.jval.2014.03.1618.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Johnson, Mallory O., Samantha E. Dilworth та Torsten B. Neilands. "Partner Reports of Patientsʼ HIV Treatment Adherence". JAIDS Journal of Acquired Immune Deficiency Syndromes 56, № 4 (2011): e117-e118. http://dx.doi.org/10.1097/qai.0b013e31820bd2ce.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Chi, Benjamin H., and Jeffrey SA Stringer. "Mobile phones to improve HIV treatment adherence." Lancet 376, no. 9755 (2010): 1807–8. http://dx.doi.org/10.1016/s0140-6736(10)62046-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Rochon, Donna, Michael W. Ross, Carol Looney, Vishnu P. Nepal, Andrea J. Price, and Thomas P. Giordano. "Communication Strategies to Improve HIV Treatment Adherence." Health Communication 26, no. 5 (2011): 461–67. http://dx.doi.org/10.1080/10410236.2011.554168.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Acri, Trisha. "2nd International Conference on HIV Treatment Adherence." Future HIV Therapy 1, no. 2 (2007): 145–48. http://dx.doi.org/10.2217/17469600.1.2.145.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Enriquez, Maithe, Nancy R. Lackey, Mary C. O'Connor, and David S. McKinsey. "Successful adherence after multiple HIV treatment failures." Journal of Advanced Nursing 45, no. 4 (2004): 438–46. http://dx.doi.org/10.1046/j.1365-2648.2003.02928.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Bogart, Laura M., Glenn J. Wagner, Matt G. Mutchler, et al. "Community HIV Treatment Advocacy Programs May Support Treatment Adherence." AIDS Education and Prevention 24, no. 1 (2012): 1–14. http://dx.doi.org/10.1521/aeap.2012.24.1.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

SZOMOLAY, BARBARA, and EDWARD M. LUNGU. "A MATHEMATICAL MODEL FOR THE TREATMENT OF AIDS-RELATED KAPOSI'S SARCOMA." Journal of Biological Systems 22, no. 03 (2014): 495–522. http://dx.doi.org/10.1142/s0218339014500247.

Full text

Abstract:

We formulate a mathematical model to study the dynamics of HIV-1 related Kaposi's Sarcoma (KS) pathogenesis. KS progression is modeled as a dual process involving the primary infection of B cells, which sustains HHV-8 replication and the secondary infection of progenitor cells by HHV-8, which sustains the KS cell replication. We incorporate the pharmacodynamics of highly active antiretroviral therapy (HAART), or combination therapy (HAART plus KS therapy) and consider how each treatment strategy alters the disease progression. Our results indicate that administration of HAART to individuals co

APA, Harvard, Vancouver, ISO, and other styles

22

Gulick, Roy M., and Charles Flexner. "Long-Acting HIV Drugs for Treatment and Prevention." Annual Review of Medicine 70, no. 1 (2019): 137–50. http://dx.doi.org/10.1146/annurev-med-041217-013717.

Full text

Abstract:

Antiretroviral drugs have revolutionized the treatment and prevention of HIV infection; however, adherence is critical for sustained efficacy. Current HIV treatment consists of three-drug regimens, and current HIV pre-exposure prophylaxis (PrEP) consists of a two-drug regimen; both generally require adherence to once-daily dosing. Long-acting formulations are useful in the treatment and prevention of other conditions (e.g., contraceptives, antipsychotics) and help promote adherence. Newer long-acting formulations of approved and investigational antiretroviral drugs in existing and newer mechan

APA, Harvard, Vancouver, ISO, and other styles

23

Kourrouski, Maria Fernanda Cabral, and Regina Aparecida Garcia de Lima. "Treatment adherence: the experience of adolescents with HIV/AIDS." Revista Latino-Americana de Enfermagem 17, no. 6 (2009): 947–52. http://dx.doi.org/10.1590/s0104-11692009000600004.

Full text

Abstract:

Living with a chronic condition is difficult at any stage of life, especially when considering HIV/AIDS, a stigmatized condition that elicits so much discrimination and which may become an aggravating factor when it occurs during adolescence. This study aimed to understand the experience of adolescents with HIV/AIDS concerning medication adherence. This is a descriptive study with a qualitative approach. Nine adolescents aged between 12 and 18 years and six caregivers participated in the study. The organization of data focused on positive and negative aspects related to adherence. The results

APA, Harvard, Vancouver, ISO, and other styles

24

Bam, Kiran, Deepak Kumar Karki, Shyam Prasad Lohani, Rajshree Thapa, Umesh Raj Aryal, and Laxmi Raj Pathak. "Adherence to Anti-Retroviral Therapy among People Living with HIV and AIDS in Far West, Nepal." Asian Journal of Medical Sciences 2, no. 1 (2011): 7–13. http://dx.doi.org/10.3126/ajms.v2i1.4290.

Full text

Abstract:

Objective: Adherence to Anti-Retroviral Therapy is a principal predictor for the success of Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) treatment. It remains as a challenge to AIDS treatment and care with the wide spread of the associated risks. The study aims to assess adherence level and factors associated with adherence to Anti-Retroviral Therapy (ART) among people living with HIV and AIDS in Far West, Nepal. Material & Methods: A cross sectional study was carried out in Far West between May 2009 to September 2009. A total of 176 samples allowed wit

APA, Harvard, Vancouver, ISO, and other styles

25

Olowookere, Samuel Anu, Akinola Ayoola Fatiregun, and Isaac F. Adewole. "Knowledge and attitudes regarding HIV/AIDS and antiretroviral therapy among patients at a Nigerian treatment clinic." Journal of Infection in Developing Countries 6, no. 11 (2012): 809–16. http://dx.doi.org/10.3855/jidc.2086.

Full text

Abstract:

Introduction: We assessed the knowledge of and attitudes toward HIV/AIDS and antiretroviral therapy (ART) in people living with HIV/AIDS (PLWHA). Methodology: A descriptive, cross-sectional study design was employed. A structured interviewer-administered questionnaire was administered to consecutive, consenting PLWHA who had been receiving treatment for a minimum of three months. The level of ART adherence was calculated manually for each respondent. Results: In total 318 PLWHA completed the questionnaire. The mean and median time on ART was 17.8 months and 19 months respectively. The mean age

APA, Harvard, Vancouver, ISO, and other styles

26

Oladigbolu, Remi A., Mansur O. Oche, Mansur O. Raji, Godwin J. Gana, and Zainab A. Ezenwoko. "Effect of telephone calls and text message reminder interventions on the adherence to antiretroviral drugs among HIV/AIDS clients receiving care in Sokoto state, Nigeria." International Journal Of Community Medicine And Public Health 7, no. 10 (2020): 3773. http://dx.doi.org/10.18203/2394-6040.ijcmph20204339.

Full text

Abstract:

Background: Adherence to antiretroviral therapy (ART) has been proven to be a good predictor of clinical outcome among patients on ART. This study aimed to assess the effect of phone reminder interventions on the knowledge of Human immunodeficiency syndrome (HIV)/ Acquired immunodeficiency syndrome (AIDS), ART and adherence to ART drugs among non-adherent patients receiving care in Sokoto State.Methods: A quasi-experimental study was conducted among 196 non-adherent HIV patients between February and July 2017. The intervention group received monthly telephone calls and weekly text messages for

APA, Harvard, Vancouver, ISO, and other styles

27

Petróczi, Andrea, Kim Hawkins, Gareth Jones, and Declan P. Naughton. "HIV Patient Characteristics that Affect Adherence to Exercise Programmes: An Observational Study." Open AIDS Journal 4, no. 1 (2010): 148–55. http://dx.doi.org/10.2174/1874613601004010148.

Full text

Abstract:

Background: Benefits of exercise for HIV-infected persons have been documented, although in clinical practice, diminished adherence to exercise limits the effectiveness of this auxiliary treatment. Exercise intervention studies carry the caveat that the results are limited to volunteers with good compliance and completion profiles. Objectives: This study aimed to identify characteristics contributing to adherence vs non-adherence to prescribed supervised 10-week 75-minute aerobic and progressive resistance exercise programme in a clinical setting that requires twice-weekly attendance at the ph

APA, Harvard, Vancouver, ISO, and other styles

28

Mattam, Bheemesh Naidu, Mounika Akurathi, B. M. S. G. Krishna, and Haritha Reddy Tumati. "Evaluation of factors influencing drug adherence to anti retroviral therapy (ART) in a tertiary care hospital, Guntur Andhra Pradesh, India." International Journal of Basic & Clinical Pharmacology 6, no. 6 (2017): 1323. http://dx.doi.org/10.18203/2319-2003.ijbcp20172030.

Full text

Abstract:

Background: Antiretroviral therapy (ART) adherence is a primary determinant of the effectiveness of Human immunodeficiency virus/Acquired immune deficiency syndrome (HIV/AIDS) treatment and is also considered a major predictor of survival among patients living with HIV/AIDS. The present study measures the level of adherence to antiretroviral drug therapy in Guntur district using Morisky medication adherence scale-8 (MMAS-8) and various factors influencing the degree of adherence.Methods: This was a cross sectional, semi structured questionnaire based study conducted over a period of 13 months

APA, Harvard, Vancouver, ISO, and other styles

29

Martínez, L., E. Boix, L. González, et al. "Mood disorders in HIV infection." European Psychiatry 41, S1 (2017): S482. http://dx.doi.org/10.1016/j.eurpsy.2017.01.569.

Full text

Abstract:

IntroductionPsychiatric disorders, particularly mood disorders, have a profound effect on the use of and adherence to highly active antiretroviral therapy (HAART) among patients with human immunodeficiency virus (HIV) infection.HIV infection and mood disorders have features in common, and each is a significant risk factor for the other.ObjectiveThe objective is to highlight the clinicians on the importance of screening and treating affective disorders among patients with HIV infection.MethodsTwo cases of HIV infected patients with comorbid mood disorder and torpid evolutions by poor adherence

APA, Harvard, Vancouver, ISO, and other styles

30

Barbosa, Paula Saraiva Duailibe, Loise Dantas Fonseca Ribeiro, Maria Eliane Liégio Matão, Pedro Humberto Faria Campos, and Denismar Borges Miranda. "Adherence to antiretroviral treatment for hiv positive pregnant women." Revista de Enfermagem UFPE on line 4, no. 4 (2010): 1823. http://dx.doi.org/10.5205/reuol.1182-9562-1-le.0404201033.

Full text

Abstract:

ABSTRACTObjective: to adherence to antiretroviral therapy by pregnant women living with HIV / AIDS and its determinants advantages and constraints. Method: this is about an exploratory descriptive study, from qualitative approach, using socioeconomic data collection questionnaire and open interviews in depth, content analysis to establish the themes. The study was approved by the Ethics in Research of the Mother and Child Hospital (protocol number 023/07). Results: the material was sorted and grouped into two themes: “HIV/AIDS: infection dramatically worldwide” and “Pregnancy and Seropositivit

APA, Harvard, Vancouver, ISO, and other styles

31

Soto Blanco, José M., Isabel Ruiz Pérez, and Joan C. March. "Adherence to antiretroviral therapy among HIV-infected prison inmates (Spain)." International Journal of STD & AIDS 16, no. 2 (2005): 133–38. http://dx.doi.org/10.1258/0956462053057503.

Full text

Abstract:

This cross-sectional study was carried out in two Spanish prisons. A group of 177 HIV-infected prison inmates were interviewed. Standardized personal interviews using a structured questionnaire were conducted to assess sociodemographic features and prison setting characteristics, clinical variables, social support and drug consumption. A simplified four-item questionnaire for self-reported adherence was used. A total of 24.3% were non-adherent. Predictors of non-adherence in the multivariate analysis included poor or lack of ability to follow the prescribed treatment regimen, no visits in a mo

APA, Harvard, Vancouver, ISO, and other styles

32

Naar-king, S., M. Frey, M. Harris, and C. Arfken. "Measuring adherence to treatment of paediatric HIV/AIDS." AIDS Care 17, no. 3 (2005): 345–49. http://dx.doi.org/10.1080/09540120412331299753.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Ka'opua, L. S. I., and C. W. Mueller. "Treatment Adherence among Native Hawaiians Living with HIV." Social Work 49, no. 1 (2004): 55–63. http://dx.doi.org/10.1093/sw/49.1.55.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Curtis, Jena Nicols. "HIV/AIDS Adherence: Teaching About Treatment and Stigma." American Journal of Sexuality Education 3, no. 1 (2007): 87–96. http://dx.doi.org/10.1300/j455v03n01_06.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Södergård, B., M. Halvarsson, M. P. Tully, et al. "Adherence to treatment in Swedish HIV-infected patients." Journal of Clinical Pharmacy and Therapeutics 31, no. 6 (2006): 605–16. http://dx.doi.org/10.1111/j.1365-2710.2006.00782.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Johnson, Mallory O., Samantha E. Dilworth, Jonelle M. Taylor, Lynae A. Darbes, Megan L. Comfort, and Torsten B. Neilands. "Primary Relationships, HIV Treatment Adherence, and Virologic Control." AIDS and Behavior 16, no. 6 (2011): 1511–21. http://dx.doi.org/10.1007/s10461-011-0021-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Vian, Taryn, Mary Bachman DeSilva, Howard J. Cabral, et al. "The role of motivation in predicting antiretroviral therapy adherence in China." Journal of Health Psychology 23, no. 14 (2016): 1895–904. http://dx.doi.org/10.1177/1359105316672922.

Full text

Abstract:

Patient motivation is important in managing medication regimens such as antiretroviral treatment for HIV/AIDS. We tested whether self-determination theory could predict adherence behavior among 115 HIV-positive patients in the China Adherence through Technology Study, a randomized controlled trial of an intervention using text reminders and supportive counseling to increase adherence. Being in the treatment group had a significant effect on improving adherence; however, we did not find evidence that self-determination theory predicts adherence in this population of HIV-positive patients. Auton

APA, Harvard, Vancouver, ISO, and other styles

38

Yusmaniar, Yusmaniar, and Adin H. Kurniawan. "Medication Adherence to Successful Tuberculosis Treatment Outcome among TB/HIV Patient at Prof. Dr. Sulianti Saroso Infectious Disease Hospital." Pharmacology and Clinical Pharmacy Research 5, no. 3 (2020): 98. http://dx.doi.org/10.15416/pcpr.v5i3.29166.

Full text

Abstract:

Tuberculosis/Human Immunodeficiency Virus (TB/HIV) co-infection has poorer treatment outcome compared to non-co-infected patients. To benefit from therapy and to avoid contracting treatment-resistant strains, the individuals must adherent to medications. There is limited information regarding successful TB treatment outcomes and their associated factors. Thus, the study was designed to identify medication adherence associated with treatment outcomes among TB/HIV Patients at Prof. Dr. Sulianti Saroso Infectious Disease Hospital. This research was an observational study with retrospective approa

APA, Harvard, Vancouver, ISO, and other styles

39

Mallya, Sneha Deepak, Veena Ganesh Kamath, Suma Nair, and Asha Kamath. "DOES PROVIDING FREE ANTI-RETROVIRAL THERAPY ENSURE OPTIMAL ADHERENCE AMONG PEOPLE LIVING WITH HIV / AIDS?" Asian Journal of Pharmaceutical and Clinical Research 9, no. 6 (2016): 172. http://dx.doi.org/10.22159/ajpcr.2016.v9i6.14019.

Full text

Abstract:

AbstractIntroduction/Back ground: Availability of Anti-Retroviral Therapy (ART) has revolutionalised the management of Human Immunodeficiency Virus /Acquired Immuno Deficiency Syndrome (HIV/AIDS) and improved the survival of those infected with the virus. However, adherence to therapy is a prerequisite for treatment success and preventing drug resistance. Aim: The present study was carried out with the aim of determining the level of adherence and factors affecting it among patients receiving free ART. Methods: A cross sectional study design was adopted and 320 HIV positive patients receiving

APA, Harvard, Vancouver, ISO, and other styles

40

Olugbenga, Ijaodola Aremu. "Determinants of HIV Treatment Adherence in Ethnically Diverse and Economically Disadvantaged Patients in a Tertiary Hospital, Nigeria." TEXILA INTERNATIONAL JOURNAL OF PUBLIC HEALTH 9, no. 2 (2021): 358–67. http://dx.doi.org/10.21522/tijph.2013.09.02.art031.

Full text

Abstract:

Antiretroviral Therapy (ART) Has Decreased The Mortality And Morbidity Of HIV/AIDS, And High Adherence To ART (>95%) Is Necessary For A Good Therapeutic Outcome. Non-Adherence Can Lead To Drug-Resistant HIV Caused By Failure To Achieve Maximal Viral Suppression. Little Is Known About Adherence To ART And Its Determinants Among Ethnically Diverse And Economically Disadvantaged Patients. The Purpose Of The Study Was To Identify The Level Of Adherence And Describe Factors That Influence ART Adherence Among Ethnically Diverse And Economically Disadvantaged Patients. This Is With A View To Provi

APA, Harvard, Vancouver, ISO, and other styles

41

Subbiah, Suthanthira Kannan, Suganya Kuppovi Reddy, Jayakrishnan Thavody, and Thomas Bina. "Prevalence and factors associated with adherence to highly active anti-retroviral therapy among patients living with HIV and AIDS in a tertiary care unit in Kozhikode." International Journal Of Community Medicine And Public Health 7, no. 8 (2020): 3223. http://dx.doi.org/10.18203/2394-6040.ijcmph20203404.

Full text

Abstract:

Background: Adherence to therapy is central to the success of anti-retroviral treatment (ART) and one of the most important factors influencing long term prognosis of HIV infection. In order to achieve this, patients are required to maintain more than 95% adherence to achieve lasting suppression of viral replication. The objective of the study was to assess the adherence to highly active antiretroviral therapy among people living with HIV (PLHIV) and the factors associated with adherence.Methods: This was a cross-sectional study conducted among PLHIV patients attending ART clinic, government m

APA, Harvard, Vancouver, ISO, and other styles

42

Farhoudi, Behnam, Amin Alipour, Saeed Ghodrati, SeyedAhmad SeyedAlinaghi, Mehrangiz Zanganeh, and Minoo Mohraz. "Barriers to Adherence of Antiretroviral Treatment in a Prison of Tehran: A Qualitative Study." Global Journal of Health Science 9, no. 6 (2016): 161. http://dx.doi.org/10.5539/gjhs.v9n6p161.

Full text

Abstract:

Focus group discussion (FGD) was conducted on Ghezel-hesar prison of Karaj, Alborz province, to investigate the barriers to and facilitators of adherence to antiretroviral therapy (ART) in January, 2015.<strong> </strong> Participants reported illegal drug use, deficits in educating patients regarding HIV treatment, side effects of anti-retroviral drugs, treatment interruption, drug interactions, fear of hangover, poor diet, low socioeconomic background, hopelessness, depression, not believing in the treatment, rejection and lack of social support, stigma, obligatory break in the p

APA, Harvard, Vancouver, ISO, and other styles

43

Hernández Huerta, D., C. Parro Torres, A. Madoz Gúrpide, E. Ochoa Mangado, and M. J. Pérez Elias. "Relationship between executive functions and adherence to antiretroviral therapy in HIV-infected patients." European Psychiatry 33, S1 (2016): S368—S369. http://dx.doi.org/10.1016/j.eurpsy.2016.01.1321.

Full text

Abstract:

IntroductionHIV-related damage of the central nervous system is manifested in varying severity of neurocognitive disturbances. Research on measures of executive functioning has confirmed that HIV infection is associated with progressive difficulties in these abilities. Moreover, several studies in recent years have shown that an impaired cognitive function confers a higher risk of poor adherence to antiretroviral therapy.Objectives/AimsThe aim of this study is to analyze the relationship between executive functions and ART compliance.MethodsWe designed a cross-sectional case-control survey. Ca

APA, Harvard, Vancouver, ISO, and other styles

44

Reid, E., C. Orrell, K. Stoloff, and J. Joska. "Psychotropic prescribing in HIV." Southern African Journal of HIV Medicine 13, no. 4 (2012): 188. http://dx.doi.org/10.4102/sajhivmed.v13i4.115.

Full text

Abstract:

Psychiatric disorders frequently co-occur with HIV, as preceding conditions or consequent to HIV infection. This potentially compromises HIV diagnosis and antiretroviral (ARV) treatment adherence. We provide a brief guide to the diagnosis and treatment of common mental disorders in people living with HIV/AIDS, including: prescribing psychotropics in HIV; neuropsychiatric side-effects of ARVs and other medications commonly prescribed in HIV; and the diagnosis and treatment of depression, anxiety, psychosis, agitation, sleep disturbance, pain, and mania. Psychotropic treatments recommended were

APA, Harvard, Vancouver, ISO, and other styles

45

Moorthy, Ganesh S., Linden Lalley-Chareczko, Helen C. Koenig, and Athena F. Zuppa. "Tenofovir Urine Assay to Monitor Adherence to HIV Pre-exposure Prophylaxis." Current Clinical Pharmacology 15, no. 2 (2020): 102–4. http://dx.doi.org/10.2174/1574884714666191111125348.

Full text

Abstract:

Tenofovir Disoproxil Fumarate (TDF) and tenofovir Alafenamide (TAF) are prodrugs of tenofovir and have excellent long-term efficacy and tolerability for the treatment of HIV. An objective marker of adherence to tenofovir-based therapy could be clinically useful in supporting adherence to TDF-based HIV pre-Exposure Prophylaxis (PrEP) in populations in whom, self-report has been shown to be unreliable, and could play a role in resource-limited settings to support HIV and hepatitis B treatment adherence. A semi-quantitative high-performance liquid chromatographymass spectrometry method for tenofo

APA, Harvard, Vancouver, ISO, and other styles

46

Cadosch, Dominique, Sebastian Bonhoeffer, and Roger Kouyos. "Assessing the impact of adherence to anti-retroviral therapy on treatment failure and resistance evolution in HIV." Journal of The Royal Society Interface 9, no. 74 (2012): 2309–20. http://dx.doi.org/10.1098/rsif.2012.0127.

Full text

Abstract:

The adherence of patients to therapy is a crucial factor for successful HIV anti-retroviral therapy. Imperfect adherence may lead to treatment failure, which can cause the emergence of resistance within viral populations. We have developed a stochastic model that incorporates compartments of latently infected cells and virus genotypes with different susceptibilities to three simultaneously used drugs. With this model, we study the impact of several key parameters on the probability of treatment failure, i.e. insufficient viral suppression, and the emergence of resistance. Specifically, we cons

APA, Harvard, Vancouver, ISO, and other styles

47

Dumitrescu, Florentina, and Eugenia-Andreea Marcu. "RISK OF MOTHER-TO-CHILD TRANSMISSION IN HIV-HEPATITIS B VIRUS COINFECTION." Romanian Journal of Infectious Diseases 24, no. 2 (2021): 109–13. http://dx.doi.org/10.37897/rjid.2021.2.8.

Full text

Abstract:

Introduction. Human immunodeficiency virus (HIV) and hepatitis B virus (HBV) are two major causes of death worldwide. These two viruses share routes of transmission, and therefore, HIV–HBV coinfection is common and is associated with low plasma levels of CD4 T lymphocytes and accelerated liver disease progression. Maternal HIV and HBV infections have been individually associated with preterm birth and low birth weight. Case presentation. We describe the case of a 28-year-old patient, 14 weeks pregnant, asymptomatic, who performed Elisa-HIV 1,2 test within prenatal screening, with a positive re

APA, Harvard, Vancouver, ISO, and other styles

48

Schreiner, Nathanial, Joseph Perazzo, Sarah Digenarro, Jackson Currie, Barbara Daly, and Allison Webel. "Examining the Association between Item Specific Treatment Burden and Adherence in People Living with HIV." Western Journal of Nursing Research 42, no. 7 (2019): 495–502. http://dx.doi.org/10.1177/0193945919880317.

Full text

Abstract:

For the 1.1 million people with HIV (PWH) in the United States, adherence to a HIV anti-retroviral medication regimen, engagement in regular physical activity, and eating a healthy diet are essential for maintaining optimal health. However, treatment burden can increase the risk for self-management non-adherence. We analyzed data of 103 men and women diagnosed with HIV to examine the relationship between medication, physical activity, and diet-related treatment burden to corresponding measures of self-management adherence. Multivariate analysis demonstrated that one medication treatment burden

APA, Harvard, Vancouver, ISO, and other styles

49

Ekama, S. O., E. C. Herbertson, E. J. Addeh, et al. "Pattern and Determinants of Antiretroviral Drug Adherence among Nigerian Pregnant Women." Journal of Pregnancy 2012 (2012): 1–6. http://dx.doi.org/10.1155/2012/851810.

Full text

Abstract:

Background. The need for a high level of adherence to antiretroviral drugs has remained a major hurdle to achieving maximal benefit from its use in pregnancy. This study was designed to determine the level of adherence and identify factors that influence adherence during pregnancy.Method. This is a cross-sectional study utilizing a semistructured questionnaire. Bivariate and multiple logistic regression models were used to determine factors independently associated with good drug adherence during pregnancy.Result. 137 (80.6%) of the interviewed 170 women achieved adherence level of ≥95% using

APA, Harvard, Vancouver, ISO, and other styles

50

Isaeva, E. R., A. D. Buzunova, and S. A. Buzunova. "PROBLEMS OF DISABILITY AND TREATMENT ADHERENCE IN HIV-INFECTED PATIENTS." Scientific Notes of the I. P. Pavlov St. Petersburg State Medical University 25, no. 3 (2018): 80–88. http://dx.doi.org/10.24884/1607-4181-2018-25-3-80-88.

Full text

Abstract:

Introduction.This study focuses on the problem of early disability of patients with HIV-infection and treatment adherence and dispensary observation. Material and methods. The clinical and anamnestic analysis of 1136 out-patient records and medical records of patients registered at Saint-Petersburg State Budgetary Institution of Healthcare “Center for Prevention and Control of AIDS and Infectious Diseases” and directed at medical and social examination was carried out. In addition, using the test methods we investigated the psychosocial characteristics of 76 patients who applied to the psychol

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!